Invesco’s Co-Diagnostics CODX Stock Holding History

Invesco’s Portfolio CODX Stock Details CODX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-460	Closed	-$132K	–	3977
2021 Q1	$132K	Buy	+460	New	+$184K	﹤0.01%	3732

Other funds holding CODX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

ARC

Advisor Resource Council Dallas, Texas $355M AUM 30.05% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco's CODX Position: Q2 2021 in Review

Invesco sold out of Co-Diagnostics (CODX) in Q2 2021, closing a stake of 460 shares — an estimated $132K sold.

Invesco first reported a position in CODX in Q1 2021 and held it in 1 quarter. The position peaked at $132K in Q1 2021. 88 funds tracked by Wall St. Rank hold CODX as of Q2 2021.

Invesco reported no remaining Co-Diagnostics position as of Q2 2021 after selling out during the quarter.
Invesco sold 460 Co-Diagnostics shares in Q2 2021, an estimated $132K.
Invesco first reported a position in Co-Diagnostics in Q1 2021 and held it in 1 quarter.
Invesco's Co-Diagnostics position peaked at $132K in Q1 2021.
88 funds tracked by Wall St. Rank held Co-Diagnostics as of Q2 2021.

Based on Invesco's 13F filing for Q2 2021, filed 17 Aug 2021.